Complexity of interactions between voriconazole and antiretroviral agents.
about
New and investigational triazole agents for the treatment of invasive fungal infections.Diagnosis and Management of Cryptococcal Relapse.Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.Methods for the quantitative evaluation and prediction of CYP enzyme induction using human in vitro systems.Rifampin-Mediated Induction of Tamoxifen Metabolism in a Humanized PXR-CAR-CYP3A4/3A7-CYP2D6 Mouse Model.Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction.Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing.
P2860
Q37364295-1E637FA2-4E25-45B2-B74A-21440BC6034CQ37409922-AAB05437-7ED2-4972-8FF9-F83BBF04D3F0Q37631771-B89E7437-4BC4-4C8D-9D1A-2F3AECE4C6CCQ37845854-06A5806C-A224-4A76-8891-84348CFEAEF4Q37918556-56765551-EA58-468D-A5A5-0D5ADF38B465Q37962449-1D3902D7-1B70-4174-90CB-79B586154F0FQ38028549-51D9BAF2-47F0-4046-8629-C56AB8ACC86FQ39476381-745BC096-A863-4C2B-B178-298540D6F186Q42198022-B3EE5A64-F799-4447-94D3-A4B930628A76Q46248271-465F7FF1-B73D-4F77-9E4C-9F50D89D5A50Q49430203-FEFD38B1-3ED6-4102-AE1F-5371EC264C85Q51110220-15F47171-BA28-4324-BB94-5D4365340A7F
P2860
Complexity of interactions between voriconazole and antiretroviral agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complexity of interactions between voriconazole and antiretroviral agents.
@en
Complexity of interactions between voriconazole and antiretroviral agents.
@nl
type
label
Complexity of interactions between voriconazole and antiretroviral agents.
@en
Complexity of interactions between voriconazole and antiretroviral agents.
@nl
prefLabel
Complexity of interactions between voriconazole and antiretroviral agents.
@en
Complexity of interactions between voriconazole and antiretroviral agents.
@nl
P2093
P2860
P356
P1476
Complexity of interactions between voriconazole and antiretroviral agents.
@en
P2093
Christine A Hughes
Erin M Yakiwchuk
Michelle M Foisy
P2860
P304
P356
10.1345/APH.1K530
P407
P577
2008-04-15T00:00:00Z